Institute of Experimental Cancer Research

Director:

  • Prof. Dr. Susanne Sebens


The Institute of Experimental Cancer Research (IET) was established in 2009 as part of the Krebszentrum Nord/Comprehensive Cancer Center within the framework of the application for an oncological centre of excellence.

The IET is a central interface between experimental and translational research as well as between laboratory and clinic. Currently six groups are working on causes of the initiation and progression of gastrointestinal tumors and the identification of therapy resistance mechanisms. The molecular biological diagnostics of metastasis of these tumors is another research focus. In this context, biomarkers are a useful tool for predictive and prognostic purposes.

The IET hosts also the oncological Biobank BMB CCC which is operated jointly with the Department of General Surgery, Abdominal, Thoracic, Transplantation and Paediatric Surgery and the Department of Pathology and is a member of the central biobank network (P2N) of the Faculty of Medicine.

Research at the IET is conducted in close cooperation with the imaging centre MOIN-CC, the Cluster of Excellence 'Inflammation at Interfaces and the Kiel Oncology Network.